Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, Catania University, Catania, Italy.
PLoS One. 2012;7(9):e44316. doi: 10.1371/journal.pone.0044316. Epub 2012 Sep 6.
Dopamine (DA) receptors, a class of G-protein coupled receptors (GPCRs), have been targeted for drug development for the treatment of neurological, psychiatric and ocular disorders. The lack of structural information about GPCRs and their ligand complexes has prompted the development of homology models of these proteins aimed at structure-based drug design. Crystal structure of human dopamine D(3) (hD(3)) receptor has been recently solved. Based on the hD(3) receptor crystal structure we generated dopamine D(2) and D(3) receptor models and refined them with molecular dynamics (MD) protocol. Refined structures, obtained from the MD simulations in membrane environment, were subsequently used in molecular docking studies in order to investigate potential sites of interaction. The structure of hD(3) and hD(2L) receptors was differentiated by means of MD simulations and D(3) selective ligands were discriminated, in terms of binding energy, by docking calculation. Robust correlation of computed and experimental K(i) was obtained for hD(3) and hD(2L) receptor ligands. In conclusion, the present computational approach seems suitable to build and refine structure models of homologous dopamine receptors that may be of value for structure-based drug discovery of selective dopaminergic ligands.
多巴胺(DA)受体是一类 G 蛋白偶联受体(GPCR),已成为药物开发的靶点,用于治疗神经、精神和眼部疾病。由于缺乏 GPCR 及其配体复合物的结构信息,因此开发了这些蛋白的同源模型,旨在进行基于结构的药物设计。人多巴胺 D3(hD3)受体的晶体结构最近已被解析。基于 hD3 受体的晶体结构,我们生成了多巴胺 D2 和 D3 受体模型,并使用分子动力学(MD)方案对其进行了细化。从 MD 模拟的膜环境中获得的细化结构随后用于分子对接研究,以研究潜在的相互作用位点。通过 MD 模拟区分了 hD3 和 hD2L 受体的结构,并通过对接计算以结合能的形式区分了 D3 选择性配体。hD3 和 hD2L 受体配体的计算和实验 K(i)值之间具有很好的相关性。总之,本计算方法似乎适用于构建和细化同源多巴胺受体的结构模型,这可能对基于结构的选择性多巴胺能配体药物发现有价值。